December 9, 2011 — Voting in favor of the norelgestromin/ethinyl estradiol transdermal contraceptive patch (Ortho Evra, Jannsen), a US Food and Drug Administration (FDA) advisory panel today ...
The U.S. Food and Drug Administration approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that ...
The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?
EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...
Blood clot risk elevated with contraceptive patches, vaginal rings Women who use the combined contraceptive transdermal patch or vaginal ring are at significantly higher risk for venous thrombosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results